IL4-receptor target therapy in colorectal cancer using AP1 peptide-guided liposome-encapsulated doxorubicin
碩士 === 國立陽明大學 === 微生物及免疫學研究所 === 101 === Colorectal cancer (CRC) has became the most frequently encountered cancer and the third most common cause of cancer-related death in Taiwan since 2007. The cause of CRC mortality is mainly due to the resistance to treatment and the occurrence of distant metas...
Main Authors: | Ya-Ching Tsai, 蔡雅晴 |
---|---|
Other Authors: | Chi-Hung Lin |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/13859665618055579957 |
Similar Items
-
Biological characterization and pharmacokinetic study of doxorubicin-encapsulated IL-4R-targeting liposomal drug in a tumor-bearing animal model
by: Wen-Chun Tsai, et al.
Published: (2012) -
Qualitative and quantitative analysis of hematoporphyrin and doxorubicin co-encapsulated in the liposomes
by: Ying-Jun Zhou, et al.
Published: (2007) -
Synthesis and characterization of a thermosensitive liposome encapsulated with nanoparticles and doxorubicin
by: Priyanka Yadav, et al.
Published: (2015) -
Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin.
by: Chen Zhao, et al.
Published: (2013-01-01) -
Targeted Cancer Therapy with Liposomal Doxorubicin
by: Yun-Long Tseng, et al.
Published: (1999)